NURO News Alert Neurometrix Inc (NURO) 1.67 12/17/2014 02:03

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Neurometrix Inc (NURO) 1.67 $NURO

NeuroMetrix Selected to Showcase Quell(TM) Wearable Pain Relief Technology at 2015 CES Unveiled
Business Wire - Tue Dec 16, 6:00AM CST
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will join an exclusive number of companies to participate in CES Unveiled, the official press event of the International Consumer Electronics Show in Las Vegas in January 2015.
NURO: 1.67 (unch)

Natus Medical (BABY) Hits 52-Week High on Bullish Trends - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 1:05PM CST
Shares of Natus Medical Inc. (BABY) scaled a 52-week high of $35.93 on Dec 9 and closed a trifle lower at $35.70, representing a healthy year-to-date return of approximately 58.7%.
JNJ: 102.76 (-1.20), BABY: 34.43 (-0.46), ALOT: 14.41 (-0.10), NURO: 1.67 (unch)

NeuroMetrix Expands Intellectual Property for Wearable Pain Relief Technology
Business Wire - Wed Dec 10, 6:00AM CST
NeuroMetrix, Inc. (Nasdaq: NURO) reported today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent application covering unique aspects of the Company's wearable pain relief technology. The patent addresses an important element in the Company proprietary OptiTherapy(TM) technology that automatically controls nerve stimulation to optimize pain relief. In particular, the patent covers the automated calibration procedure that determines the appropriate stimulation level for each device user. The Company expects the patent to issue in mid-2015 and to extend patent protection into 2032. The technology is incorporated in the currently marketed prescription SENSUS(R) pain management device and in Quell(TM) which will be unveiled at the International Consumer Electronics Show (CES) in Las Vegas in January 2015.
NURO: 1.67 (unch)

NeuroMetrix to Participate in the Benchmark Micro Cap Discovery Conference
Business Wire - Mon Dec 08, 11:59AM CST
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be participating in the one-on-one Benchmark Micro Cap Discovery Conference which will be held at the Palmer House Hilton, Chicago, IL on Thursday, December 11, 2014 from 8:00am to 2:30pm. Dr. Gozani intends to provide a business update and discuss development progress on Quell(TM), the Company's over the counter wearable pain relief device which will be unveiled at the International Consumer Electronics Show (CES) in Las Vegas in January 2015. To schedule a one-on-one meeting with Dr. Gozani please e-mail vcuratola@benchmarkcompany.com or contact your Benchmark representative.
NURO: 1.67 (unch)

NeuroMetrix to Unveil Revolutionary Wearable Pain Relief Device at 2015 International Consumer Electronics Show
Business Wire - Wed Nov 19, 6:00AM CST
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will unveil Quell(TM), the Company's wearable pain relief device at the International Consumer Electronics Show (CES) in Las Vegas in January 2015.
NURO: 1.67 (unch)

NeuroMetrix ups revenues 8% in Q3
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 12:44PM CDT

NURO: 1.67 (unch)

NeuroMetrix's (NURO) CEO Shai Gozani on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 10:31AM CDT

NURO: 1.67 (unch)

NeuroMetrix Q3 EPS of -$0.19
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 6:07AM CDT

NURO: 1.67 (unch)

NeuroMetrix Reports Third Quarter 2014 Financial Results and Business Highlights
Business Wire - Tue Oct 28, 6:00AM CDT
--Progress with over-the-counter wearable device to treat chronic pain
NURO: 1.67 (unch)

NeuroMetrix reports October 28
Seeking Alpha - at Seeking Alpha - Tue Oct 21, 6:43AM CDT

NURO: 1.67 (unch)

NeuroMetrix, Inc. Announces Date for 2014 Third Quarter Financial Results Conference Call
Business Wire - Tue Oct 21, 6:00AM CDT
NeuroMetrix, Inc. (the "Company" (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today said it plans to issue its 2014 third quarter financial results before the opening of the market on October 28, 2014. The Company will host a conference call at 8:00 a.m., Eastern Time on October 28, 2014 to discuss its financial results as well as business developments affecting the Company.
NURO: 1.67 (unch)

3 Breakout Stocks Under $10 for Your Watch List
at The Street - Wed Oct 08, 7:25AM CDT
Keep an eye on these under-$10 stocks for breakout trades.
RDNT: 8.59 (+0.17), NURO: 1.67 (unch), FSGI: 2.09 (+0.02)

NeuroMetrix Reports Publication of Study Demonstrating that DPNCheck is Effective at Detecting Diabetic Peripheral Neuropathy at all Stages of Severity
Business Wire - Thu Sep 25, 6:00AM CDT
NeuroMetrix, Inc. (Nasdaq: NURO), today reported publication of results from a DPNCheck(R) study conducted at the Diabetes Research Unit of the Ipswich Hospital NHS Trust in the United Kingdom. The study by Sharma and colleagues titled "Assessment of Diabetic Neuropathy Using a Point-of-Care Nerve Conduction Device Shows Significant Associations With the LDIFLARE Method and Clinical Neuropathy Scoring" was published in the Journal of Diabetes Science and Technology and is available at:
NURO: 1.67 (unch)

NeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of Diabetic Complications
Business Wire - Tue Sep 23, 12:49PM CDT
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29th Annual Meeting of The Japan Society of Diabetic Complications to be held in Tokyo on October 3 and 4, 2014. The Japan Society of Diabetic Complications is a part of The Japan Diabetes Society which was established in 1958 to promote diabetes-related academic research and treatment programs. The organization has over 16,000 members and works in collaboration with other international organizations including the International Diabetes Federation (IDF), the American Diabetes Association (ADA), and the European Association for the Study of Diabetes (EASD). The Annual Meeting of the Japan Society of Diabetic Complications is one of the major events of the Japan Diabetes Society.
NURO: 1.67 (unch)

NeuroMetrix Names Senior Executive to Lead Consumer Healthcare Initiative Frank McGillin - SVP and GM, Consumer
Business Wire - Wed Sep 03, 6:00AM CDT
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer. Mr. McGillin will be responsible for development of a consumer healthcare business built on the Company's wearable therapeutic technology for treatment of chronic pain which was recently cleared by the FDA for over-the-counter use without a prescription requirement.
NURO: 1.67 (unch)

NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference
Business Wire - Tue Sep 02, 2:51PM CDT
NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel, New York, NY on September 8-10, 2014. Dr. Gozani intends to provide an update on the Company's business activities including the SENSUS(R) Pain Management System for chronic pain and sleep, and the Company's emerging consumer healthcare initiative.
NURO: 1.67 (unch)

Bacterin Announces the Appointment of New Board Member
GlobeNewswire - Wed Aug 13, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of David Goodman, MD, MSE to the board of directors. Dr. Goodman brings extensive experience in executive management through previous roles as CEO of SEDLine and EVP of Business Development for Masimo (Nasdaq:MASI). The Board unanimously elected Dr. Goodman to fill the vacancy created by Mitchell Godfrey's recent resignation. Bacterin would like to thank Mr. Godfrey for his years of service and dedication to the Company.
MASI: 24.27 (+0.12), BONE: 2.69 (-0.03), NURO: 1.67 (unch)

NeuroMetrix Reports Second Quarter 2014 Financial Results and Business Highlights
Business Wire - Thu Jul 24, 6:00AM CDT
--FDA regulatory clearance for over-the-counter wearable technology to treat chronic pain
NURO: 1.67 (unch)

NeuroMetrix Marks 10th Year Anniversary of Listing on NASDAQ
Business Wire - Tue Jul 22, 6:00AM CDT
NeuroMetrix, Inc. (NASDAQ: NURO) reported today that it had reached the 10th anniversary of its initial listing on NASDAQ.
NURO: 1.67 (unch)

NeuroMetrix, Inc. Announces Date for 2014 Second Quarter Financial Results Conference Call
Business Wire - Thu Jul 17, 2:32PM CDT
NeuroMetrix, Inc. (the "Company" (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today said it plans to issue its 2014 second quarter financial results before the opening of the market on July 24, 2014. The Company will host a conference call at 8:00 a.m., Eastern Daylight Time on July 24, 2014 to discuss its financial results as well as business developments affecting the Company.
NURO: 1.67 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 92

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 155

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 178

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 205

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 121

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 76

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 239

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 95

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Vivid Seats Simplifies Market Structure and Tax Obligations

Updated Category News Views 221

Vivid Seats Streamlines Corporate Structure Vivid Seats Inc. (NASDAQ: SEAT), a leading online ticket marketplace, has embarked on a transformative journey to simplify its organizational framework. In a strategic move, the company has announced its Corporate Simplification Agreement, aimed at redefining how it operates while enhancing its tax efficiency and overall...

Continue Reading
NLS Pharmaceuticals Soars After Major Merger Announcement

Updated Category News Views 330

NLS Pharmaceuticals Sees Positive Stock Movement NLS Pharmaceuticals Ltd. (NASDAQ: NLSP) is experiencing significant upward momentum in its stock prices following a crucial announcement regarding a proposed merger. The company has filed a Form F-4 registration statement with the Securities and Exchange Commission, signaling an essential step toward completing this merger....

Continue Reading
Orchestra BioMed Achieves Key Financial and Operational Progress

Updated Category News Views 84

Orchestra BioMed Reports on Financial Performance and Business Updates Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO), a pioneering biomedical innovation company, recently presented its robust financial results for Q3 2024, reflecting both significant fiscal health and promising advancements in medical technology. The company is focused on elevating patient care through...

Continue Reading
Nutex Health Inc. Investors Urged to Join Securities Class Action

Updated Category News Views 130

Investors of Nutex Health Inc. Face Opportunities Amid Allegations Investors holding shares in Nutex Health Inc. are currently presented with a remarkable opportunity in light of claims surrounding securities fraud involving the Company. Founded as a notable player in the healthcare sector, Nutex Health has recently come under scrutiny due to alleged misleading statements...

Continue Reading
Empowering Resilience in Education: Embracing Failure with LetMeFail

Updated Category News Views 182

Transforming Education: LetMeFail's Innovative Approach LetMeFail is an exciting new educational initiative aimed at transforming how students perceive and deal with failure. In today's culture, where perfection is often idolized, this program makes it clear that setbacks can serve as important stepping stones toward personal growth and resilience. Unpacking the Goals of...

Continue Reading